Ramsay Générale de Santé (GDS) CMD 2026 summary
Event summary combining transcript, slides, and related documents.
CMD 2026 summary
17 Sep, 2026Strategic vision and roadmap
Launched Connecting Care 2030, a multi-year plan focused on profitable growth, medical excellence, digital transformation, and integrated care across Europe, building on prior diversification and innovation.
Five strategic pillars: integrated healthcare, digital transformation, active portfolio management, cost initiatives, and new revenue streams.
Emphasis on leveraging medical excellence, people, data/AI, brand, sustainability, customer centricity, and IT infrastructure as core capabilities.
Outpatient and digital patient growth prioritized, with internal referrals fueling a significant share of patient volume.
Expansion in primary care, imaging, and mental health, leveraging cross-country innovation and digital tools.
Financial performance and guidance
Revenue reached €5.4 billion in FY2026, with a 3.9% CAGR over the last two years; EBITDA margin improved to 11.9%.
Guidance for 2027–2029: 2–3% average annual revenue growth, stable then gradually improving EBITDA margin, gross CapEx at 4% of revenue, and net debt/EBITDA target below 4x.
Growth is predominantly volume-driven, with limited reliance on M&A; margin improvement expected from operational efficiency and portfolio optimization.
Capital expenditures focus on high-value segments, digital innovation, and medical equipment, with real estate policy stabilizing at 20% owned, 80% leased.
Deleveraging supported by margin gains, disciplined capital allocation, and working capital improvements.
Market positioning and operational strengths
Pan-European leader with operations in five countries, serving 13 million patients annually, and holding top market positions in France, Sweden, and Denmark.
High barriers to entry due to regulation, certifications, and medical expertise, especially in France and Sweden.
Integrated care model enables 20% of patients to be managed through internal referrals, enhancing patient pathways and efficiency.
Strong focus on digital transformation, including AI-driven tools, digital admissions, and ambient scribe technology, with best practices shared across countries.
Medical excellence recognized by external accreditations, high Net Promoter Scores (NPS), and superior clinical outcomes in key specialties.
Latest events from Ramsay Générale de Santé
- Revenue and EBITDA grew, margins held steady, and a new 2030 strategy will drive future growth.GDS
H2 2026 - Revenue up 4.7%, strong ESG progress, all resolutions approved, COSEM integration on track.GDS
Status update - Revenue up 6.5% but net loss of €53.9m as inflation and lower subsidies hit margins.GDS
H2 2024 - Revenue up 5.8% to €2.5bn, EBITDA flat, net loss widens to €43.1m; debt refinanced for growth.GDS
H1 2025 - Revenue up 8.6% and EBITDA up 15.1%, driven by growth in France and Sweden.GDS
Q1 2025 - Revenue up 5.1% to €3.89bn, EBITDA stable, but net loss widened and leverage increased.GDS
Q3 2025 - Revenue and EBITDA grew despite funding cuts, with stable net loss and improved leverage.GDS
H2 2025 - Revenue up 2.6% and EBITDA up 6.5% year-over-year, with margin and leverage improvements.GDS
Q1 2026 - Revenue up 3.3% to €2.59bn, stable EBITDA, net loss narrows, strategic changes and funding pressures persist.GDS
H1 2026